Justine E. Koenigsberg

Investor Relations Contact at CONCERT PHARMACEUTICALS, INC.

Health Technology

Commercial Services

Consumer Services

Profile

Justine E.
Koenigsberg is currently the SVP-Corporate Communications & Investor Relations at Concert Pharmaceuticals, Inc. She is also a Member at the National Investor Relations Institute.
In 2023, she will start working as the Vice President-Investor Relations at Kymera Therapeutics, Inc. Previously, Ms. Koenigsberg worked as the Director-Corporate Communications at Transkaryotic Therapies, Inc. She also held the position of Director-Investor & Media Relations at ViaCell, Inc. Additionally, she worked as a Principal at Vertex Pharmaceuticals, Inc.Ms. Koenigsberg completed her undergraduate degree at Northeastern University.

Justine E. Koenigsberg active positions

Companies	Position	Start
CONCERT PHARMACEUTICALS, INC.	Investor Relations Contact	2008-02-29
KYMERA THERAPEUTICS, INC.	Investor Relations Contact	2023-06-30
National Investor Relations Institute National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA.	Corporate Officer/Principal	-

All active positions of Justine E. Koenigsberg

Former positions of Justine E. Koenigsberg

Companies	Position	End
Transkaryotic Therapies, Inc. Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA.	Public Communications Contact	-
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	-
ViaCell, Inc. ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA.	Public Communications Contact	-

See the detail of Justine E. Koenigsberg's experience

Training of Justine E. Koenigsberg

Northeastern University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Justine E. Koenigsberg's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology
KYMERA THERAPEUTICS, INC.	Health Technology

Private companies	4
Transkaryotic Therapies, Inc. Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA.	Commercial Services
ViaCell, Inc. ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA.	Health Technology
Concert Pharmaceuticals, Inc. Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.	Health Technology
National Investor Relations Institute National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA.	Commercial Services

See company connections